Meta Health eyes 30% of Aios Bio Sciences share capital

It is part of Meta Health’s efforts to grow the group’s healthcare business

Meta Health Limited is eyeing to acquire 30% of the entire issued and paid-up share capital of Aios Bio Sciences from Davin Ng and other shareholders.

The transaction is part of Meta Health’s efforts to grow the group’s healthcare business and diversify its revenue streams by expanding into the complementary segment of the manufacturing and distribution of medical and surgical consumables.

Aios Bios is a private company limited by shares incorporated in Singapore on 25 July 2022.

Based on the information extracted from the Accounting and Corporate Regulatory Authority, Ng is a director of the company and holds 33.3% of the entire issued and paid share capital.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia